Home > Insider Trading > Filing (0000899243-19-019423)

Filing Details

Accession Number:: 0000899243-19-019423
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-10 16:05:44
Reporting Period:: 2019-07-08

Accepted Time:: 2019-07-10 16:05:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610664	Cesare Orlandi	C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-07-08	6,672	$21.10	75,155	No	4	M	Direct
Common Stock	Acquisiton	2019-07-08	13,346	$21.10	88,501	No	4	M	Direct
Common Stock	Acquisiton	2019-07-08	6,672	$21.10	95,173	No	4	M	Direct
Common Stock	Acquisiton	2019-07-08	8,896	$21.10	104,069	No	4	M	Direct
Common Stock	Disposition	2019-07-08	28,002	$28.33	76,067	No	4	S	Direct
Common Stock	Disposition	2019-07-08	7,584	$27.60	68,483	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-07-08	6,672	$0.00	6,672	$21.10
Common Stock	Stock Option (right to buy)	Disposition	2019-07-08	13,346	$0.00	13,346	$21.10
Common Stock	Stock Option (right to buy)	Disposition	2019-07-08	6,672	$0.00	6,672	$21.10
Common Stock	Stock Option (right to buy)	Disposition	2019-07-08	8,896	$0.00	8,896	$18.66

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2018-06-25	2023-03-04	No	4	M	Direct
	2023-03-04	No	4	M	Direct
	2023-03-04	No	4	M	Direct
	2023-08-05	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.45, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 to $27.99, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
These options vested in four equal installments on March 4, 2014, 2015, 2016 and 2017.
Options to purchase 13,345 shares of Common Stock were granted to the reporting person on March 4, 2013, which options were subject to vesting in up to four equal annual installments based upon the level of LNTH's satisfaction of certain performance criteria for each of fiscal years 2013, 2014, 2015 and 2016. A certain level of the performance criteria were satisfied for each of fiscal years 2013 and 2014, resulting in the partial vesting as to 6,672 shares of Common Stock.
These options vested in four equal installments on August 5, 2014, 2015, 2016 and 2017.